In contrast, DTA co-mutations with non-DTA genes were observed in 7 cases (30.4%), more commonly in patients with prior solid tumors than in those with hematologic malignancies, though this difference did not reach statistical significance ( p =0.619).
← all excerpts
Impact of primary cancer history and molecular landscape in therapy-related myeloid neoplasms.
1
0.6190
0.6190